PMS-Pazopanib 200 mg tablet; Presence of Sorafenib
Last updated
Summary
Product
PMS-Pazopanib 200 mg tablet
Issue
Health products - Product quality
What to do
Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.
Affected products
Issue
Presence of Sorafenib in affected lots.
What you should do
- Verify if your product is affected.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Pharmascience Inc.
6111 Avenue Royalmount,
Montréal, Québec, H4P 2T4, Canada
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Identification number
RA-73740
Get notified
Receive notifications for new and updated recalls and alerts by category.